Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis

Recruiting N/A Interventional Study
Clinical High Risk for Psychosis (CHR)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
14 – 25
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
72 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Psychosis typically emerges during late adolescence or early adulthood, significantly impacting long-term functioning. While CHR programs have the potential to reduce illness severity, individuals often face barriers such as stigma and limited access …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Age 14-25 * Ability to participate in assessments and treatment in English * Meets criteria for psychosis-risk on SIPS * Stable on medications; no changes within 1 month prior to enrollment * Identification of one "family member" with \>4 hours/week contact who is willing to p…
Contacts

Yulia Landa, PsyD, MS

212-585-4658

yulia.landa@mssm.edu

CONTACT

Rachel Jespersen, LMSW

212-585-4641

rachel.jespersen@mssm.edu

CONTACT